SINGAPORE (Oct 28): DBS Group Research is maintaining its “buy” call Japfa with higher $1.18 target, encouraging investors to take advantage of the attractive valuations offered by the Indonesia-based supplier of animal protein.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $4.99/month*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply